
REVISION
@revision_trial
Early REperfusion Therapy with Intravenous Thrombolysis for Recovery of VISION in Acute Central Retinal Artery Occlusion: phase III randomized trial
ID: 1742539324388687872
http://www.revision-trial.de 03-01-2024 13:32:13
21 Tweet
51 Followers
160 Following

📢Great new paper by first author Tobias Geisler from the Department of #Cardiology and Angiology Uniklinikum Tübingen & our own Sven Poli, head of the #Stroke and #Neuroprotection Lab at the HIH.


Fascinating talks at the 2024 Stroke Research Center Bern StrokeWinterSchool #CRAO by Sven Poli #sICH by Kilian Treurniet #TIA by LinxinLi





🙌 Big thanks to Teams @LMU_Uniklinikum, Uniklinikum Tübingen and most importantly Team Universitätsklinikum Leipzig for randomizing their 1st patient 🥇into the #revision_trial interventional study (#38, overall 88 patients). @DominikMichalski @JohannPelz @FockeZiemssen @ClaudiaJochmann @RitaLachmund

Featuring keynote lecture from Anne Hege Aamodt Anne Hege Aamodt from the University of Oslo whose work validated clinical efficacy of tenecteplase. She will update on treatment of strokes in the eye (CRAO) and TenCRAOs trial. Brian Mac Grory Sven Poli valerie Biousse Oana Dumitrascu MD, MSc, FAHA, FAAN


👁️🧠 Study protocol of the REVISION (IVT in central retinal artery occlusion) just published at International Journal of Stroke 🔔 Motivated EU stroke centers may contact us and still join Sven Poli Hertie-Zentrum für Neurologie Uniklinikum Tübingen Carsten Grohmann Boehringer Ingelheim @BMBF_Bund doi.org/10.1177/174749…





👏👏 Frankfurt Team Dan Rowden. Jan Hendrik Schäfer (neurology) and Gerry Scheetz. Thomas Kohnen (ophthalmology) enrolled patient #65 into the #revision_trial intervention trial Total enrollments 136 patients ⬆️💪 Sven Poli Carsten Grohmann

